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Age-related reference intervals (RIs) of central (aortic) systolic blood pressure (cSBP) and augmentation index (cAIx) obtained from
large healthy population are lacking in Argentina (South America). Aims. To analyze the existence of associations among cSBP and
cAIx with demographic, anthropometric, and hemodynamic parameters and to generate percentile curves and RIs adjusted to each
level of age and gender and/or body height. cSBP and cAIx were measured in 1038 healthy children, adolescents, and young adults.
First, we evaluated if RIs for males and females were necessary using correlation and covariate analysis. Second, mean (M) and
standard deviation (SD) age-related equations were obtained for cSBP and cAIx, using parametric regression methods based on
fractional polynomials. Third, age specific percentiles curves were generated. Fourth, body height specific percentiles curves were
generated using a similar procedure.The obtained equations (considering age as independent variable) for all subjects (cSBP0.26 and
(cAIx + 12.001)0.5) were as follows: cSBP Mean = 3.0581 + 0.2189 log(Age) − 0.001044Age; cSBP SD = −0.03919 + 0.1535 log(Age) −
0.004564Age; cAIx mean = 9.5226 − 6.1599 log(Age) + 0.1450Age; cAIx SD = 1.3880 − 0.8468 log(Age) + 0.03212Age. This study,
performed in Argentinean healthy children, adolescents, and young adults with ages of 5 to 22 years, provides the first RIs and
percentile curves of cSBP and cAIx. Additionally, specific body height-related cAIx percentiles are reported for the analyzed
population. The RIs and percentiles contribute to the knowledge of arterial dynamic evolution along the normal aging process
and the interpretation of data obtained in clinical research and daily clinical practice.
1. Introduction
The analysis and monitoring of vessels morphology and
function in young people have become of major interest
for both pediatricians and adult specialists in order to
preserve and optimize cardiovascular health from childhood
to adulthood [1]. The noninvasive assessment of arterial
stiffness (AS) provides valuable information of structural
and functional state of the vascular system, beyond that of
the conventional blood pressure (BP) measurements [2]. For
instance, increases in AS in adolescents and young adults are
associated with left ventricular mass index, independently of
traditional cardiovascular risk factors (CRFs) [3]. Screening
for AS may be useful to identify subjects with cardiovascular
risk in children, adolescents, and young adults’ populations
[3].
There are several parameters to assess AS being frequently
used the aortic pulse wave velocity (PWV) and augmentation
index (AIx) of the aorta and the brachial artery. PWVandAIx
increase with the arterial aging process [4–6]. Is important
to take into account the fact that PWV is widely considered
a direct marker of AS [7], while the AIx is a well-known
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modality to express arterial wave reflections, often considered
as a surrogate index of AS [6–8].
Linked to AIx assessment, central (aortic) systolic blood
pressure (cSBP) is a parameter that strongly reflects vascular
changes of central elastic arteries compared to peripheral
(brachial) BP, both in adults and children and adolescents
[9, 10]. Moreover, changes in cSBP levels affect the heart,
brain, and kidneys which are directly exposed to them [11].
Central arterial and haemodynamic parameters (cAIx
and cSBP) can be estimated noninvasively using a good num-
ber of techniques. They include Doppler ultrasound, appla-
nation tonometry, oscillometry, and magnetic resonance
imaging; all of them are associated with its own strengths and
weaknesses [2, 12]. Oscillometric devices have been suggested
to be especially adequate in children and adolescents, since
the methodology includes the use of a simple pressure cuff
and have the advantages of being relatively fast, operator
independent and require minimal cooperation of the patient
[13, 14].
Independently of the technique or device used to assess
the arterial properties, there are several gaps in the approach
of cSBP and cAIx measurements [1], performed in pediatric
clinical practice such as (a) what are the interval references
(RIs) of cSBP and cAIx values for each measurement? And
(b) do they differ by gender and/or body height?
The2016European Society ofHypertension guidelines for
the management of high BP in children and adolescents do
not recommend the routine assessment of arterial parameters
and cSBP, however, highlights the need to increase knowledge
in the field of arterial parameters as markers of function of
the vascular system [15]. Furthermore, the 2013 ESH/ESC
guidelines for the management of arterial hypertension con-
sidered that cSBP can provide useful information in young
patients with isolated systolic hypertension [16]. Moreover,
cSBP may be especially relevant in asymptomatic children
and adolescents incidentally found to have isolated systolic
hypertension without target organ damage [15].
Unfortunately, at present few epidemiological studies in
healthy pediatric populations are available, in which RIs of
cSBP and cAIx were obtained using brachial oscillometric
cuffmethod [17, 18]. To the best of our knowledge, the largest
databases of RIs of cSBP and cAIx in pediatrics come from
Hungary [17] and Germany, in which the Arteriograph and
Mobil-O-Graph System were respectively used [18].
Considering the lack of knowledge in terms of cSBP and
cAIx reference values for children, adolescents, and young
adults fromArgentina, our research purposes were as follows:
(1) to analyze the existence of associations among cSBP
and cAIx with demographic, anthropometric, and hemody-
namic parameters,
(2) to generate percentile curves and RIs adjusted to each
level of age and (if required) gender and/or body height.
2. Materials and Methods
This study is part of a project started in 2014 in Tandil city
(Buenos Aires Province), Argentina, aimed at investigating
the prevalence of CRFs. Preliminary data obtained in this
location have been previously reported [19–21]. Tandil is
located 360Km south of Buenos Aires City (37∘19󸀠08󸀠󸀠S-
9∘08󸀠05󸀠󸀠W).
The study protocol was approved by the Institutional
Ethics Committee and was carried on in agreement with
the Declaration of Helsinki and the Good Clinical Practice
Guidelines. Written informed consent was obtained from the
participants or authorized person.
Asymptomatic children, adolescents, and young adults
(5–22 years old) from the Tandil community were considered
for enrolment in this study. Subjects were submitted to
clinical interview, blood sampling evaluation, and anthropo-
metric assessment, carried out in all cases by the same group
of physicians. Blood samples were obtained after 9–12 hours
of fasting. Glycaemia, lipid profile, and kidney functional
parameters were determined. Anthropometric evaluation
and a brief clinical interview allowed assessing CRFs expo-
sure. Asymptomatic subjects included in the study met the
following criteria: (1) none had history of cardiovascular,
pulmonary, or renal disease; (2) normal peripheral BP at
the time of examination (BP ≤ 140/90mmHg in adults and
BP < 90th percentile in subjects < 16 years old) [15]; (3)
none were taking medications (antihypertensive, antihyper-
lipidemic, or antidiabetic drugs); (4) all included subjects had
glycaemia< 6.11mmol/L (<110mg/dl), total blood cholesterol
levels < 5.17mmol/L (<200mg/dl) [16], and normal serum
triglycerides levels < 1.69mmol/L (<150mg/dl), ≤1.5mmol/L
(<130mg/dl), and ≤1.13mmol/L (<100mg/dl) for subjects
older than 18 years, subjects between 10 to 17 years, and
children under 10 years, respectively [15, 22].
Current and past smokers, diabetic, obese subjects (body
mass index [BMI] ≥ 30 kg/m2 for adults or BMI ≥ 97th
percentile for subjects under 18 years old), hypertensive
subjects, or subjects with averaged high brachial BP levels at
the time of the study were excluded. To this end, peripheral
(brachial) BP measurements were obtained using fully auto-
matic sphygmomanometers, operating on oscillometric prin-
ciple (705IT, Omron Healthcare Inc., USA). Adults’ BP levels
were classified following guidelines for the management of
arterial hypertension [16]. Thus, hypertension was defined as
peripheral systolic BP (pSBP) ≥ 140mmHg and/or peripheral
diastolic BP (pDBP) ≥ 90mmHg. In turn, brachial BP levels
in children and adolescents were categorized, taking into
account sex, age, and body height, according to criteria of the
American Pediatrics Association and the European Society of
Hypertension report [15].
2.1. Augmentation Index and Blood Pressure Measurements.
All measurements were performed using the Arteriogrph
system (Arteriograph; TensioMed Ltd, Budapest, Hungary)
after 10 minutes of rest in a quiet room with stable temper-
ature (22 ± 1∘C). The Arteriograph system is an operator-
independent noninvasive device that applies an oscillometric,
occlusive technique by use of an upper-arm cuff to register
brachial pressure waves.
The mentioned device was used to assess simultaneously
central (aortic) systolic and pulse pressure (cSBP, cPP) and
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peripheral (brachial) systolic, diastolic, pulse, and mean BP
levels (pSBP, pDBP, pPP and MAP, resp.). The measurement
procedure takes approximately 3 minutes and is operatively
comparable to an automatic digital BP oscillometricmeasure-
ment. In this study, the same device was used for all measure-
ments. The working principle and the invasive validations
of this method have been detailed previously [6, 23]. The
method is based on the physiological fact that the early (𝑃1)
systolic pulse pressure wave of the aorta, generated by the left
ventricle ejection, travels along the aorta and is reflected (𝑃2)
from the area of the aortic bifurcation.Occluding the brachial
artery by pressurizing the cuff 35–40mmHg above the actual
SBP creates easily distinguished, pronounced pressure peaks
in the cuff. Separated in this way, early and late systolic waves
can be recorded.The time lapses between the peaks of𝑃1 and
𝑃2 are equal to the travel time of the aortic pressurewave from
the aortic root to the bifurcation and back. By halving this
time and measuring the sternal notch, pubic bone distance
(which is rather close to the true aortic length [24], the
Ao-PWV can be calculated (Ao-PWV = jugulum-symphysis
distance/transit time). Additionally, the Arteriography sys-
tem calculates the brachial augmentation index (bAIx) using
the formula: bAIx (%) = (𝑃2 − 𝑃1/PP) × 100. The cAIx
was calculated based on invasive measurements previously
reported [23], which showed a very strong linear correlation
between bAIx and cAIx (𝑅 = 0.94, 𝑝 < 0.001). These studies
showed a strong and significant correlation between the inva-
sively obtained values and oscillometrically measured cAIx,
cSBP, and aortic PWV. Taking into account the influence
of heart rate on cAIx [25], in each subject the mentioned
index was calculated corresponding to 75 beats by minute
(cAIx-HR75).
2.2. Data Analysis. In this research, a step-wise data analysis
was done as is described in the following.
First, aiming at determining whether RIs analysis for
cAIx and cAIx-HR75 was necessaries, we separately assessed
the degree of association (correlation) and equivalence
(agreement) between cAIx and cAIx-HR75 levels, by study-
ing potential mean and/or proportional differences (errors)
betweenmeasurements and constructing limits of agreement
(correlation and Bland-Altman analysis). As a first result,
specific RIs for cAIx and cAIx-HR75 were defined as not
necessaries. About this, both variables showed a great asso-
ciation (cAIx = −0.2753 + 0.9957 ⋅ cAIx-HR75; 𝑅2 = 0.9953).
However, despite a statistically significant difference between
both variables (mean error = −0.3167%, 𝑝 < 0.0001; mean
error 95% confidence interval = −0.3522% to −0.2811%; mean
error standard deviation (SD) = 0.5836%, 95% confidence
interval = −1.4605% to 0.8272%), the difference was not con-
sidered clinically significant, as to force the generation of RIs
separately (for cAIx and cAIx-HR75).
Second, we evaluated if RIs for males and females were
necessary. To this end, bivariate and point-biserial correla-
tions were done (Table 2), and after that gender influence
was examined before and after adjustment for cofactors (i.e.,
age, BP) applying covariance analysis (ANCOVA) (Table 3).
ANCOVA allows comparing one variable (i.e., cSBP or cAIx)
in two or more groups (i.e., males versus females) taking into
account (or to correct for) variability of other variables, called
covariates or cofactors. With this purpose, correlations were
done to identify demographic, anthropometric (i.e., body
height, body weight) and/or hemodynamic (i.e., heart rate,
pSBP, and pDBP) variables that in theory could be consid-
ered as cofactors in covariate analysis. Once the variables
significantly associated with cSBP and cAIx were identified,
ANCOVA analysis was done adjusting for them (Table 3).
With this purpose, several models (cofactors combinations)
were analyzed. Always, prior to the ANCOVA test, Levene’s
test for equality of variances and homogeneity of regression
slopes test were performed. If Levene’s test is positive (𝑝 <
0.05) then the variances in the groups are different (the
groups are not homogeneous), and therefore the assumptions
for ANCOVA are not met. Additionally, the interpretation of
ANCOVA and the associated adjusted (or marginal) means
relies on the assumption of homogeneous regression slopes
for the compared groups (i.e., males and females); if this
assumption is not met (𝑝 < 0.05) the ANCOVA results are
unreliable. After statistical analysis, as a result, generation
of specific cSBP and cAIx RIs for males and females was
considered as necessaries.
Third, the mean value and SD age-related equations
(for males and females) were obtained for cSBP and cAIx.
With this purpose, parametric regression methods based
on fractional polynomials (FPs), as described by Royston
and Wright [26] and previously used to generate RIs for
arterial parameters in the European Arterial Stiffness Col-
laboration Group methodological strategy [27, 28], were
implemented using MedCalc Software (MedCalc, Ostend,
Belgium). Briefly, fitting FPs for age specific cSBP and cAIx
mean value and SD regression curves were defined using
iterative procedure (generalized least squares, GLS). The
obtained results enabled estimating age specific mean and
SD for both parameters (cSBP and cAIx). For instance, cAIx
mean equation could be cAIx = 𝑎 + 𝑏 ∗ age𝑝 + 𝑐 ∗ age𝑞 + ⋅ ⋅ ⋅ ,
where 𝑎, 𝑏, 𝑐, . . . are the coefficients, and 𝑝, 𝑞, . . . are the
powers, with numbers selected from the set [−2, −1, −0.5,
0, 0.5, 1, 2, 3] estimated from the regression for the mean
cAIx curve and likewise from the regression for the SD curve.
Continuing the example, FPs with powers [1, 2], that is, with
𝑝 = 1 and 𝑞 = 2, illustrate an equation with the form
𝑎 + 𝑏∗ age + 𝑐 ∗ age2 [26]. The residuals were used to
assess the model fit, which was deemed appropriate if the
scores were normally distributed, with a mean of 0 and a
SD of 1, randomly scattered above and below 0 when plotted
against age. The best fitted curves, considering visual and
mathematical criteria (Kurtosis and Skewness coefficients),
were selected. Then, using the equations obtained for mean
and SD, age specific percentiles were defined using the
standard normal distribution (𝑍) (Tables 4, 5, and 6 for
cSBP and Tables 7, 8, and 9 for cAIx). Age specific 1th,
2.5th, 5th, 10th, 25th, 50th, 75th, 90th, 95th, 97.5th, and
99th percentile curves were calculated as mean cAIx + Zp
∗ SD, where Zp assumed the values of −2.3263, −1.9599,
−1.6448, −1.2815, −0.6755, 0, 0.6755, 1.2815, 1.6448, 1.9599,
and 2.3263, respectively. The obtained equations were as
follows:
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(i) For all subjects (cSBP0.26 and (cAIx + 12.001)0.5),
cSBP Mean = 3.0581 + 0.2189 log (Age)
− 0.001044Age
cSBP SD = −0.03919 + 0.1535 log (Age)
− 0.004564Age
cAIx Mean = 9.5226 − 6.1599 log (Age) + 0.1450Age
cAIx SD = 1.3880 − 0.8468 log (Age)
+ 0.03212Age.
(1)
(ii) For males (cSBP1.13 and (cAIx + 7.001)0.53),
cSBP Mean = 146.7373 + 5.4105 log (Age)
+ 1.7801Age
cSBP SD = −10.3739 + 39.2556 log (Age)
− 1.2532Age
cAIx Mean = 7.4365 − 3.7152 log (Age)
+ 0.05135Age
cAIx SD = −1.2276 + 3.4356 log (Age)
− 0.1113Age.
(2)
(iii) For females (cSBP0.26 and (cAIx + 12.001)0.66),
cSBP Mean = 2.9920 + 0.3501 log (Age)
− 0.007039Age
cSBP SD = −0.07844 + 0.2039 log (Age)
− 0.005824Age
cAIx Mean = 21.8535 − 18.4253 log (Age)
+ 0.5115Age
cAIx SD = 3.2466 − 1.6274 log (Age)
+ 0.03122Age.
(3)
Finally, a similar procedure was performed to obtain cAIx
RIs considering the body height (BH) [17]. The obtained
equations were as follows:
For males (cAIx + 7.001)0.53,
cAIx Mean = −16.3756 + 13.9683 log (BH)
− 0.06468BH
cAIx SD = −14.8123 + 8.6667 log (BH)
− 0.02016BH.
(4)
For females (cAIx + 12.001)0.66,
cAIx Mean = −46.6729 + 35.8589 log (BH)
− 0.1523BH
cAIx SD = 38.0202 − 21.0915 log (BH)
+ 0.06424BH.
(5)
In the equations detailed above, always cSBP, cAIx, Age, and
BH were expressed in mmHg, %, years, and centimeters,
respectively.
Limit of statistical signification was considered when
a 𝑝 value < 0.05 was found. Calculus of the minimum
sample size required was calculated taken into account a
normal distribution of the covariate (age) in the sample (in a
conservative way) and a 95% and 90% limit of reference and
confidence interval (two sided), respectively, with a 95% and
10% reference range and relative margin of error, respectively.
In this research, the minimum required sample size for RIs
construction (i.e., for males or females) was 377 subjects
[29].
3. Results
3.1. General Characteristics of the Analyzed Population. In
this research 1038 healthy subjects (576 males and 462
females) were included. In Table 1 the characteristics of all
children, adolescents, and young adults are summarized,
discriminating values obtained for males and females. Mean
age for the whole population was 15.35 ± 3.15 years (range
5.00–21.92 y.o.) and no significant age differences were found
(Table 1). In this cohort, males showed the highest body
weight, body height, and BMI values (𝑝 < 0.001). Also, males
exhibit significant higher jugulum-symphysis distance than
females (𝑝 < 0.001). Mean values of pSBP and pPP obtained
in males were significantly higher than those obtained in
females (𝑝 < 0.001); on the contrary pDBP and HR were
significantly lower in males compared with females. No
significant differences related to gender in terms of pMAP
values were observed. Moreover, males have higher mean
values of cSBP and cPP than females (𝑝 < 0.05 and𝑝 < 0.001,
resp.). See Table 1.
No significant gender differences in peripheral AIx, ejec-
tion duration, and Ao-PWV mean values were observed in
the analyzed population. Obtained mean values of cAIx and
cAIx-HR75 were always higher in females than in males (𝑝 <
0.001). See Table 1.
3.2. Analysis of cSBP and cAIx Associations. As was men-
tioned significant differences between cAIx and cAIx-HR75
were found; however absolutely values of these differences
were really minimal (mean error = −0.3167, 𝑝 < 0.0001;
mean error 95% confidence interval = −0.3522 to −0.2811;
mean error SD= 0.5836, 95% confidence interval =−1.4605 to
0.8272). Consequently, taking into account the RIs generated
in terms of cAIx, it was evidenced that it was not necessary
to generate RIs using cAIx-HR75 obtained values. That
is to say, percentiles generated using cAIx or cAIx-HR75
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Table 1: Children and adolescents characteristics.
All (1038) Male (𝑛 = 576) Female (𝑛 = 462) 𝑝 value (male
versus female)MV SD Min Max MV SD Min Max MV SD Min Max
Age (years) 15.35 3.15 5.00 21.92 15.51 2.84 5.00 21.75 15.15 3.49 5.17 21.92 0.068
Body height (cm) 162.67 13.98 102.00 191.00 167.15 13.72 104.00 191.00 157.09 12.20 102.00 178.00 <0.001
Body weight (Kg) 57.00 14.14 15.00 96.00 61.39 14.70 15.00 96.00 51.51 11.22 18.00 75.00 <0.001
BMI (Kg./m2) 21.17 3.11 7.90 29.40 21.60 3.14 13.60 29.40 20.64 2.98 7.90 27.82 <0.001
Jugulo -symphysis
distance (cm) 47.48 4.96 28.00 74.00 49.13 4.87 28.00 74.00 45.44 4.27 28.00 56.00 <0.001
Heart rate (b.p.m.) 68.43 12.17 44.00 113.00 65.49 11.83 44.00 104.00 72.09 11.60 44.00 113.00 <0.001
Peripheral SBP
(mmHg) 111.81 9.58 81.00 135.00 114.01 9.64 89.00 135.00 109.06 8.78 81.00 134.00 <0.001
Peripheral MBP
(mmHg) 79.07 7.49 8.00 102.00 79.24 7.68 8.00 98.00 78.86 7.25 61.00 102.00 0.412
Peripheral DBP
(mmHg) 62.71 7.51 3.00 89.00 61.97 7.17 36.00 82.00 63.63 7.84 3.00 89.00 <0.001
Peripheral PP
(mmHg) 48.96 8.29 .49 86.00 51.99 8.12 31.00 86.00 45.17 6.81 .49 70.00 <0.001
Central (aortic) SBP
(mmHg) 98.86 8.39 75.20 124.90 99.35 8.40 78.00 124.90 98.24 8.36 75.20 121.00 0.035
Central (aortic) PP
(mmHg) 36.26 5.88 21.80 62.90 37.43 5.72 21.80 62.90 34.78 5.75 23.20 58.60 <0.001
Peripheral (brachial)
AIx (%) −1.34 7.01 −85.00 .60 −1.64 8.12 −85.00 .29 −.96 5.31 −84.00 .60 0.122
cAIx (%) 9.20 8.46 −12.00 45.90 6.67 7.40 −7.00 36.00 12.35 8.64 −12.00 45.90 <0.001
cAIx HR75 (%) 9.51 8.49 −12.34 45.61 7.12 7.45 −7.82 36.53 12.49 8.76 −12.34 45.61 <0.001
Return time (ms) 173.47 21.17 14.00 310.00 178.91 19.43 85.00 230.00 166.68 21.32 14.00 310.00 <0.001
Ejection duration
(ms) 299.06 22.73 185.00 385.00 297.90 21.09 185.00 360.00 300.49 24.59 190.00 385.00 0.068
Ao-PWV (m/s) 5.50 .63 3.40 7.70 5.51 .64 3.40 7.70 5.48 .62 3.90 7.70 0.607
BMI: bodymass index. SBP,MBP, DBP, and PP: systolic, mean, diastolic, and pulse blood pressure, respectively. AIx: augmentation index. cAIx and cAIxHR75:
central (aortic) augmentation index net value and normalized for heart rate equal 75 beats/minute, respectively. Ao-PWV: Aortic pulse wave velocity. Min and
Max: minimal and maximal value, respectively. A 𝑝 < 0.05 was considered statistically significant.
were very similar and observed differences were lack of
clinical relevance. In other words, the difference was not
considered clinically significant, as to force the generation of
RIs separately (for cAIx and cAIx-HR75).
Table 2 show the bivariate and point-biserial correlation
study of cSBP, cAIx, and Age relationship with demographic,
anthropometric, hemodynamic, and vascular parameters of
the analyzed population. As can be seen in Table 2, the age
and the anthropometric parameters show a positive and
significantly associationwith cSBP and cAIx levels.Moreover,
HR shows borderline statistic values of association with cSBP
(𝑝 = 0.079).
Table 3 show a covariance (ANCOVA) study destined to
determine if the gender discrimination would be necessary
in the RIs of cSBP and cAIx generation using data collected
in this research. Also in Table 3, the noncorrected and cor-
rected marginals’ means values with standard error and 95%
confidence intervals are given for males and females. In the
case of cSPB, a first analysis induces to think that adjustments
using Models 1, 2, 3, and 4 show no statistically significantly
gender differences. However, the comparison of regression
lines obtained from males and females showed statistically
significant differences; that is to say there are different slopes
of the cSBP-age regression lines (see homogeneity of regres-
sion slope’s test in Table 3(a)). As the ANCOVA analysis and
the associated adjusted means values rely on the assumption
of the homogeneity of regression slopes in the studied groups.
If this assumption is not met (𝑝 < 0.05) the ANCOVA results
are unreliable; consequently, in the analyzed population, it
is absolutely necessary to perform different RIs for cSBP for
males and females (Table 3(a)). Similar results were obtained
when sex-related differences in cAIx were analyzed using
Models 3 and 4 (Table 3(b)). Moreover, for all considered
models, sex-related differences after Levene’s test for equality
of variances were also demonstrated (different in terms of
the calculated variance). Again, if Levene’s test is positive
(𝑝 < 0.05) the variances in the analyzed groups should be
considered statistically different (the groups are not homoge-
neous); so the assumption of homogeneity is not met and the
ANCOVA analysis is invalid. As a consequence of the results
obtained in cAIx ANCOVA analysis, sex-related RIs should
be necessary in this population (Table 3(b)).
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Table 2: Association between aortic characteristics and anthropometric and haemodynamic parameters.
Central (aortic) SBP (mmHg) cAIx (%) Age (years)
Sex (0: male; 1: female) R −.066 .334 −.057
P .035 .000 .068
Age (years) R .263 −.188 1.000
P .000 .000 .000
Body height (cm) R .238 −.371 .678
P .000 .000 .000
Body weight (Kg) R .318 −.362 .617
P .000 .000 .000
BMI (Kg/m2) R .320 −.215 .414
P .000 .000 .000
Yugulo-symphysis distance (cm) R .242 −.378 .656
P .000 .000 .000
Heart rate (b.p.m.) R .054 .005 −.358
P .079 .881 .000
Peripheral SBP (mmHg) R .892 −.216 .308
P .000 .000 .000
Peripheral MBP (mmHg) R .863 −.016 .293
P .000 .617 .000
Peripheral DBP (mmHg) R .720 .107 .236
P .000 .001 .000
Peripheral PP (mmHg) R .385 −.336 .131
P .000 .000 .000
Central (aortic) SBP (mmHg) R 1.000 .164 .263
P .000 .000 .000
Central (aortic) PP (mmHg) R .525 .180 .040
P .000 .000 .202
Peripheral (brachial) AIx R −.018 .079 −.079
P .571 .011 .011
cAIx (%) R .164 1.000 −.188
P .000 .000 .000
cAIx HR75 (%) R .162 .997 −.160
P .000 .000 .000
Ejection duration (ms) R −.026 .207 .096
P .396 .000 .002
Return time (ms) R −.118 −.327 .152
P .000 .000 .000
Ao-PWV (m/s) R .374 .010 .456
P .000 .757 .000
BMI: body mass index. SBP, MBP, DBP, and PP: systolic, mean, diastolic, and pulse blood pressure, respectively. AIx: augmentation index. cAIx and cAIx
HR75: central (aortic) augmentation index net value and normalized for heart rate equal 75 beats/minute, respectively. Ao-PWV: aortic pulse wave velocity. A
𝑝 < 0.05 was considered statistically significant.
3.3. Reference Intervals (Percentile Analysis) Obtained in the
Analyzed Population. As is shown in Table 4, specific per-
centiles of age-cSBP values for five-year age RIs were gen-
erated including the entire population (𝑛 = 1038), that is,
including males and females. Furthermore, a similar analysis
was carried out using values corresponding to each year of age
(TableA in SupplementaryMaterials). As seen inTable 5, age-
cSBP percentiles corresponding to 5-year age intervals were
generated for males (𝑛 = 576). A similar analysis was done
for each year of age, as seen in Table B (see Supplementary
Materials). Females (𝑛 = 462) were analyzed using a similar
method, and the obtained RIs can be seen in Table 6 and
Table C (see Supplementary Materials). Figures 1(a), 1(b),
and 1(c) show specific age-cSBP percentiles for the entire
population, males and females, respectively. As expected,
there was a positive association between age and cSBP values,
representing a gradual and continuous increase in terms of
cSBP.
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Table 4: Age-related reference intervals (RIs) for central (aortic) systolic blood pressure for the entire population (𝑛 = 1038).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th
5.0 77.6 79.2 80.7 82.3 85.1 88.3 91.6 94.6 96.5 98.1 100.0
6.0 77.5 79.4 81.0 83.0 86.3 90.0 93.9 97.5 99.7 101.7 104.0
7.0 77.5 79.6 81.5 83.6 87.3 91.5 95.9 99.9 102.4 104.6 107.2
8.0 77.7 79.9 81.9 84.2 88.2 92.8 97.5 102.0 104.7 107.1 109.9
9.0 77.9 80.3 82.4 84.8 89.0 93.9 99.0 103.7 106.6 109.1 112.2
10.0 78.2 80.7 82.9 85.4 89.8 94.9 100.2 105.1 108.2 110.8 114.0
11.0 78.6 81.2 83.4 86.0 90.5 95.8 101.3 106.4 109.5 112.3 115.6
12.0 79.0 81.6 83.9 86.6 91.2 96.6 102.2 107.4 110.7 113.5 116.9
13.0 79.5 82.1 84.5 87.2 91.9 97.4 103.1 108.4 111.7 114.6 118.0
14.0 80.0 82.7 85.0 87.8 92.5 98.0 103.8 109.2 112.5 115.4 118.9
15.0 80.5 83.2 85.6 88.3 93.1 98.7 104.5 109.9 113.2 116.2 119.7
16.0 81.1 83.8 86.1 88.9 93.7 99.3 105.1 110.5 113.8 116.7 120.3
17.0 81.7 84.4 86.7 89.5 94.3 99.8 105.6 111.0 114.3 117.2 120.7
18.0 82.3 85.0 87.3 90.1 94.8 100.3 106.0 111.4 114.7 117.6 121.1
19.0 83.0 85.6 87.9 90.6 95.3 100.8 106.5 111.8 115.0 117.9 121.3
20.0 83.6 86.2 88.5 91.2 95.9 101.2 106.8 112.1 115.3 118.1 121.5
21.0 84.3 86.9 89.1 91.8 96.4 101.7 107.2 112.3 115.5 118.2 121.6
21.8 84.8 87.4 89.6 92.3 96.8 102.0 107.4 112.5 115.6 118.3 121.6
Table 5: Age-related reference intervals (RIs) for central (aortic) systolic blood pressure for males (𝑛 = 576).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th
5.0 76.4 78.4 80.1 82.1 85.3 89.0 92.5 95.8 97.7 99.3 101.2
6.0 75.4 77.7 79.7 82.0 85.8 90.0 94.2 98.0 100.2 102.2 104.4
7.0 74.8 77.4 79.6 82.2 86.4 91.1 95.7 99.9 102.4 104.5 107.0
8.0 74.7 77.5 79.8 82.6 87.1 92.1 97.1 101.5 104.2 106.5 109.1
9.0 74.8 77.8 80.3 83.1 87.9 93.1 98.4 103.0 105.8 108.2 111.0
10.0 75.2 78.2 80.8 83.8 88.7 94.1 99.5 104.3 107.2 109.7 112.6
11.0 75.8 78.9 81.5 84.5 89.6 95.1 100.6 105.5 108.5 111.0 113.9
12.0 76.5 79.6 82.3 85.4 90.5 96.1 101.7 106.6 109.6 112.2 115.1
13.0 77.4 80.5 83.2 86.3 91.4 97.0 102.7 107.6 110.6 113.2 116.2
14.0 78.4 81.5 84.2 87.3 92.4 98.0 103.6 108.6 111.6 114.2 117.1
15.0 79.4 82.5 85.2 88.3 93.3 98.9 104.5 109.5 112.4 115.0 118.0
16.0 80.6 83.6 86.3 89.3 94.3 99.9 105.4 110.3 113.2 115.8 118.7
17.0 81.8 84.8 87.4 90.4 95.3 100.8 106.3 111.1 114.0 116.5 119.4
18.0 83.1 86.0 88.6 91.5 96.4 101.7 107.1 111.9 114.7 117.1 120.0
19.0 84.4 87.3 89.8 92.7 97.4 102.7 107.9 112.6 115.3 117.7 120.5
20.0 85.8 88.6 91.0 93.8 98.5 103.6 108.7 113.2 116.0 118.3 121.0
21.0 87.2 90.0 92.3 95.0 99.5 104.5 109.5 113.9 116.5 118.8 121.5
21.6 88.1 90.8 93.1 95.8 100.2 105.1 109.9 114.3 116.9 119.1 121.7
Tables 7, 8, and 9 show specific percentiles of age-cAIx
values for five-year age RIs corresponding to the entire
population, males and females, respectively. Furthermore, a
similar analysis was carried out using values obtained by each
year of age (Tables D, E, and F in Supplementary Materials).
Figures 2(a), 2(b), and 2(c) show specific age-cAIx percentiles
for the entire population, males and females, respectively.
As expected, there was a correlation between age and cAIx
values.
Specific percentile analysis of cAIx corresponding to
each body height level (using 5 cm intervals) of the male
cohort is shown in Table 10. Also in Table G, using
1 cm interval is provided in Supplementary Materials. Fur-
thermore, in Table 11 and Table H of the Supplemen-
tary Materials, RIs corresponding to the female cohort
are showed. Figures 3(a) and 3(b) show body height-cAIx
percentiles, corresponding to males and females, respec-
tively.
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Table 6: Age-related reference intervals (RIs) for central (aortic) systolic blood pressure for females (𝑛 = 462).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th
5.2 79.5 80.8 82.0 83.4 85.7 88.3 91.0 93.5 95.0 96.3 97.9
6.0 79.2 80.9 82.3 84.0 86.8 90.0 93.4 96.4 98.3 100.0 101.9
7.0 79.1 81.0 82.6 84.6 88.0 91.8 95.8 99.5 101.7 103.7 106.0
8.0 79.0 81.1 83.0 85.2 88.9 93.3 97.8 101.9 104.5 106.7 109.4
9.0 79.0 81.3 83.3 85.7 89.8 94.5 99.4 103.9 106.7 109.2 112.1
10.0 79.1 81.5 83.7 86.2 90.5 95.5 100.7 105.5 108.5 111.1 114.3
11.0 79.2 81.7 84.0 86.6 91.1 96.3 101.8 106.8 110.0 112.7 116.0
12.0 79.4 82.0 84.3 87.0 91.6 97.0 102.6 107.9 111.1 114.0 117.4
13.0 79.6 82.3 84.6 87.4 92.1 97.6 103.4 108.7 112.0 115.0 118.5
14.0 79.9 82.5 84.9 87.7 92.5 98.1 103.9 109.4 112.7 115.7 119.2
15.0 80.1 82.8 85.2 88.0 92.9 98.5 104.4 109.8 113.2 116.2 119.8
16.0 80.4 83.1 85.5 88.3 93.2 98.8 104.7 110.2 113.6 116.6 120.1
17.0 80.7 83.4 85.8 88.6 93.5 99.1 104.9 110.4 113.7 116.7 120.3
18.0 81.1 83.8 86.1 88.9 93.7 99.2 105.0 110.4 113.8 116.7 120.3
19.0 81.4 84.1 86.4 89.2 93.9 99.4 105.1 110.4 113.7 116.6 120.1
20.0 81.8 84.4 86.7 89.4 94.1 99.5 105.1 110.3 113.6 116.4 119.8
21.0 82.2 84.8 87.0 89.7 94.2 99.5 105.0 110.1 113.3 116.1 119.4
21.8 82.5 85.1 87.3 89.9 94.3 99.5 104.9 109.9 113.0 115.7 119.0
Table 7: Age-related reference intervals (RIs) for central (aortic) augmentation index (cAIx) for the entire population (𝑛 = 1038).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th
5.0 1.8 4.5 7.1 10.2 16.0 23.3 31.4 39.4 44.5 49.1 54.7
6.0 −0.1 2.4 4.7 7.5 12.8 19.3 26.7 34.0 38.6 42.8 48.0
7.0 −1.5 0.8 2.9 5.5 10.3 16.4 23.3 30.0 34.3 38.3 43.0
8.0 −2.6 −0.5 1.5 3.9 8.5 14.2 20.6 27.0 31.1 34.8 39.4
9.0 −3.4 −1.5 0.4 2.7 7.0 12.5 18.7 24.8 28.7 32.3 36.6
10.0 −4.1 −2.3 −0.5 1.7 5.9 11.2 17.1 23.0 26.8 30.3 34.5
11.0 −4.7 −2.9 −1.2 1.0 5.0 10.1 15.9 21.7 25.4 28.8 32.9
12.0 −5.2 −3.4 −1.8 0.3 4.3 9.3 15.0 20.7 24.3 27.7 31.7
13.0 −5.6 −3.8 −2.2 −0.2 3.7 8.7 14.3 19.9 23.6 26.9 30.9
14.0 −5.9 −4.2 −2.6 −0.6 3.3 8.2 13.8 19.4 23.0 26.3 30.4
15.0 −6.1 −4.5 −2.9 −0.9 2.9 7.8 13.4 19.1 22.7 26.0 30.1
16.0 −6.4 −4.7 −3.2 −1.1 2.7 7.6 13.2 18.9 22.5 25.9 30.0
17.0 −6.6 −4.9 −3.4 −1.3 2.5 7.4 13.1 18.8 22.5 25.9 30.0
18.0 −6.7 −5.1 −3.5 −1.5 2.4 7.4 13.1 18.9 22.6 26.1 30.3
19.0 −6.8 −5.2 −3.6 −1.6 2.3 7.4 13.2 19.1 22.9 26.4 30.6
20.0 −6.9 −5.3 −3.7 −1.6 2.3 7.4 13.4 19.3 23.2 26.8 31.1
21.0 −7.0 −5.4 −3.8 −1.7 2.3 7.6 13.6 19.7 23.7 27.3 31.8
21.8 −7.1 −5.4 −3.8 −1.7 2.4 7.7 13.8 20.1 24.1 27.8 32.3
4. Discussion
This research provides the first Latin American database
concerningRIs of cSBP and cAIx obtained on a large cohort of
healthy children, adolescents, and young adults aged between
5 and 22 years. Moreover, the definition of RIs generated in
this study will further improve our ability to identify young
populations at high risk and represent a first step toward
new approaches in the diagnosis andmanagement of high BP
states and/or other altered haemodynamic conditions found
in childhood and adolescence. To the best of our knowledge,
there are no widely accepted clear cutoff values for central
aortic BP levels in pediatric clinical practice, in spite of recent
efforts of European researchers [18]. In this context, our study
provides percentiles for cSBP and cAIx representing a novel
approach to optimize risk stratification in youths.
The cAIx inform about the arterial wave reflection
component of the left ventricular afterload. Values of cAIx
10 International Journal of Hypertension
Table 8: Age-related reference intervals (RIs) for central (aortic) augmentation index (cAIx) for males (𝑛 = 576).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th
5.0 4.6 6.0 7.2 8.7 11.4 14.6 18.1 21.4 23.4 25.3 27.5
6.0 1.2 2.7 4.1 5.8 8.9 12.7 16.9 21.0 23.6 26.0 28.8
7.0 −1.1 0.4 1.9 3.7 7.0 11.2 15.9 20.6 23.6 26.3 29.6
8.0 −2.6 −1.1 0.3 2.1 5.6 10.0 15.1 20.2 23.4 26.4 30.0
9.0 −3.6 −2.2 −0.8 1.0 4.5 9.0 14.3 19.7 23.1 26.3 30.2
10.0 −4.3 −3.0 −1.6 0.1 3.6 8.2 13.6 19.1 22.7 26.0 30.0
11.0 −4.8 −3.6 −2.3 −0.5 2.9 7.5 13.0 18.6 22.2 25.6 29.7
12.0 −5.2 −4.0 −2.7 −1.0 2.4 7.0 12.4 18.0 21.7 25.1 29.2
13.0 −5.4 −4.3 −3.1 −1.4 1.9 6.5 11.9 17.5 21.1 24.5 28.7
14.0 −5.6 −4.5 −3.3 −1.7 1.6 6.0 11.4 16.9 20.5 23.8 27.9
15.0 −5.6 −4.6 −3.5 −1.9 1.3 5.6 10.9 16.3 19.8 23.1 27.2
16.0 −5.7 −4.7 −3.5 −2.0 1.1 5.3 10.4 15.7 19.2 22.4 26.3
17.0 −5.7 −4.7 −3.6 −2.1 0.9 5.0 10.0 15.1 18.5 21.6 25.4
18.0 −5.6 −4.6 −3.6 −2.1 0.8 4.8 9.6 14.5 17.7 20.7 24.4
19.0 −5.6 −4.6 −3.5 −2.1 0.7 4.6 9.2 13.9 17.0 19.9 23.4
20.0 −5.4 −4.5 −3.4 −2.1 0.7 4.4 8.8 13.3 16.3 19.0 22.3
21.0 −5.3 −4.3 −3.3 −2.0 0.7 4.2 8.4 12.7 15.5 18.1 21.3
21.6 −5.2 −4.2 −3.2 −1.9 0.7 4.1 8.2 12.4 15.1 17.6 20.6
Table 9: Age-related reference intervals (RIs) for central (aortic) augmentation index (cAIx) for females (𝑛 = 462).
Age (years) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th
5.2 3.5 6.8 9.7 13.3 19.8 27.5 35.8 43.7 48.6 53.0 58.2
6.0 1.4 4.4 7.2 10.5 16.5 23.7 31.4 38.8 43.4 47.5 52.4
7.0 −0.5 2.2 4.8 7.8 13.4 20.1 27.3 34.1 38.4 42.3 46.8
8.0 −1.9 0.6 3.0 5.9 11.1 17.4 24.1 30.6 34.7 38.3 42.6
9.0 −2.9 −0.5 1.7 4.4 9.3 15.3 21.8 28.0 31.8 35.3 39.4
10.0 −3.7 −1.4 0.7 3.4 8.1 13.8 20.0 25.9 29.6 33.0 36.9
11.0 −4.2 −2.0 0.1 2.6 7.1 12.7 18.6 24.4 28.0 31.2 35.0
12.0 −4.5 −2.4 −0.4 2.0 6.4 11.8 17.7 23.2 26.7 29.9 33.6
13.0 −4.7 −2.7 −0.7 1.7 6.0 11.3 17.0 22.4 25.9 28.9 32.6
14.0 −4.8 −2.8 −0.9 1.5 5.7 10.9 16.5 21.9 25.2 28.3 31.9
15.0 −4.8 −2.8 −0.9 1.4 5.6 10.7 16.3 21.6 24.9 27.9 31.4
16.0 −4.8 −2.7 −0.8 1.5 5.6 10.7 16.2 21.4 24.7 27.7 31.2
17.0 −4.6 −2.6 −0.7 1.6 5.8 10.8 16.3 21.5 24.8 27.7 31.2
18.0 −4.4 −2.3 −0.5 1.9 6.0 11.0 16.5 21.7 25.0 27.9 31.4
19.0 −4.1 −2.0 −0.1 2.2 6.3 11.4 16.8 22.1 25.3 28.2 31.7
20.0 −3.7 −1.7 0.3 2.6 6.8 11.8 17.3 22.5 25.8 28.7 32.2
21.0 −3.3 −1.2 0.7 3.1 7.3 12.4 17.9 23.1 26.4 29.3 32.8
21.8 −3.0 −0.8 1.1 3.5 7.7 12.9 18.4 23.7 27.0 29.9 33.4
are mainly determined by two factors: (a) aortic stiffness
(which in turn determines the “central to peripheral” and
“peripheral to central” forward and backward wave compo-
nents propagation velocities) and (b) distance between aortic
root and major wave reflection sites (i.e., aortic bifurcation
at the level of pelvic arteries and include small arteries)
[30]. Increases in aortic stiffness enhance the speed of wave
reflection (resulting in an earlier return of the reflected
wave to the ascending aorta) and increase the magnitude
of the backward or reflected wave (resulting in an increase
in aortic pulse pressure and left ventricle afterload). As a
result, frequently when the AS increases the higher the cAIx
is [30]. Consequently, the cAIx inform about the vascular wall
state as a surrogate index of AS [6, 23]. Additionally, reduced
body height is associated with early arrival of reflected waves
to the ascending aorta, and consequently is associated with
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increased cAIx. Furthermore, high cAIx values implicate
that increases of cSBP and/or cPP are determined by early
arrival of reflected waves (during left ventricular systolic
period). In other words, jointly analyzing the cAIx and cSBP
or cPP, it is possible to determine if the levels of cSBP or
cPP (i.e., increased) are due (or not) to an increase in the
amplitude or early arrival of the reflected waves. Taking
into account the determinant of cAIx, subjects with similar
12 International Journal of Hypertension
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Figure 2
levels of aortic stiffness could exhibit significant differences
in cAIx associated with differences in body height. This is
particularly important in children and adolescents in which
both AS and body height are continuously changing. From
this point of view, cAIx would be a very representative index
of arterial dynamics and left ventricular afterload, since it
evaluates simultaneously AS and changes associated with
growth process.
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Table 10: Body height-related reference intervals (RIs) for central (aortic) augmentation index (cAIx) for males (𝑛 = 576).
Body height (cm) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th
104 5.06 6.36 7.54 8.95 11.43 14.41 17.59 20.62 22.51 24.20 26.23
105 4.79 6.12 7.32 8.76 11.31 14.35 17.62 20.74 22.69 24.44 26.52
110 3.54 4.97 6.26 7.83 10.64 14.03 17.70 21.23 23.45 25.44 27.83
115 2.38 3.87 5.24 6.91 9.93 13.61 17.63 21.52 23.98 26.19 28.85
120 1.31 2.85 4.26 6.01 9.18 13.10 17.41 21.61 24.28 26.69 29.59
125 0.33 1.88 3.33 5.12 8.41 12.52 17.07 21.54 24.39 26.96 30.08
130 −0.58 0.97 2.43 4.25 7.62 11.87 16.62 21.31 24.31 27.03 30.32
135 −1.41 0.11 1.57 3.40 6.82 11.17 16.07 20.93 24.06 26.89 30.33
140 −2.18 −0.69 0.75 2.57 6.01 10.42 15.43 20.43 23.65 26.58 30.14
145 −2.88 −1.44 −0.03 1.76 5.19 9.63 14.71 19.80 23.09 26.09 29.75
150 −3.51 −2.13 −0.77 0.99 4.37 8.81 13.91 19.07 22.41 25.46 29.18
155 −4.09 −2.78 −1.48 0.23 3.56 7.96 13.06 18.24 21.61 24.69 28.46
160 −4.61 −3.38 −2.14 −0.49 2.76 7.09 12.16 17.33 20.70 23.79 27.58
165 −5.07 −3.93 −2.76 −1.18 1.96 6.21 11.21 16.34 19.70 22.79 26.57
170 −5.49 −4.44 −3.34 −1.84 1.19 5.32 10.23 15.30 18.62 21.68 25.44
175 −5.85 −4.90 −3.88 −2.47 0.43 4.43 9.23 14.20 17.47 20.50 24.21
180 −6.16 −5.31 −4.38 −3.06 −0.31 3.54 8.20 13.06 16.27 19.24 22.89
185 −6.42 −5.68 −4.83 −3.61 −1.02 2.66 7.16 11.88 15.02 17.91 21.50
190 −6.63 −6.01 −5.25 −4.13 −1.71 1.80 6.12 10.68 13.72 16.54 20.03
191 −6.67 −6.07 −5.33 −4.23 −1.84 1.62 5.91 10.44 13.46 16.26 19.73
Table 11: Body height-related reference intervals (RIs) for central (aortic) augmentation index (cAIx) for females (𝑛 = 462).
Body height (cm) 1th 2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th 99th
102 −1.63 1.21 3.82 7.03 12.82 19.86 27.47 34.76 39.32 43.40 48.27
105 −1.07 1.71 4.27 7.40 13.02 19.83 27.18 34.20 38.60 42.52 47.20
110 −0.36 2.34 4.80 7.80 13.17 19.65 26.61 33.25 37.40 41.09 45.50
115 0.10 2.71 5.09 7.98 13.12 19.31 25.95 32.26 36.20 39.71 43.89
120 0.32 2.85 5.15 7.93 12.88 18.83 25.19 31.24 35.01 38.37 42.36
125 0.31 2.76 4.99 7.69 12.48 18.22 24.36 30.19 33.82 37.06 40.91
130 0.09 2.48 4.64 7.26 11.92 17.50 23.46 29.12 32.64 35.78 39.52
135 −0.32 2.01 4.12 6.68 11.22 16.67 22.49 28.02 31.47 34.53 38.19
140 −0.90 1.37 3.44 5.95 10.40 15.75 21.47 26.91 30.30 33.32 36.91
145 −1.63 0.60 2.62 5.09 9.47 14.75 20.40 25.78 29.14 32.13 35.69
150 −2.48 −0.30 1.69 4.11 8.45 13.67 19.29 24.64 27.99 30.97 34.52
155 −3.44 −1.31 0.65 3.04 7.34 12.54 18.14 23.49 26.84 29.83 33.40
160 −4.48 −2.40 −0.47 1.89 6.16 11.35 16.96 22.34 25.71 28.72 32.31
165 −5.57 −3.55 −1.66 0.68 4.92 10.11 15.75 21.18 24.58 27.63 31.27
170 −6.70 −4.74 −2.89 −0.58 3.63 8.83 14.52 20.01 23.46 26.56 30.26
175 −7.83 −5.95 −4.15 −1.88 2.31 7.53 13.28 18.84 22.36 25.51 29.29
178 −8.49 −6.67 −4.90 −2.67 1.50 6.74 12.52 18.14 21.70 24.89 28.72
On the other hand, levels of BP are mainly determined
by cardiac and vascular factors. Higher (and faster) left
ventricular stroke volume is associated with high levels of
cSBP and cPP. Otherwise, AS and arrival time and amplitude
of wave reflections are the main determinants of cSBP and
cPP, while peripheral vascular resistances and cardiac output
are the main determinants of MBP and cDBP. In this context,
it is important to emphasize that simultaneousmeasurements
of central (aortic) BP and cAIx (using a single device) in
children and adolescents allow us not only to know if cSBP
and cPP are within physiological levels, but also in case of
abnormal values to realize if they were associated or not with
increased wave reflection levels (cAIx) [31, 32].
Our data shows that, in agreement with the two largest
data bases of cSBP measurement in children and adolescents
with oscillometric techniques, males exhibit higher values
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of SBP and PP in both central and peripheral arteries [17,
18]. Despite the methodological differences (inclusion and
exclusion criteria) in addition to the different devices used
between the three studies (see Table 12), it is possible to
attempt to compare the cSBP values between our datawith the
RIs from Hungarian [17] and German pediatric population
[18] (Figure 4). In the analyzed population, the 50th per-
centile corresponding to boys and girls aged between 5 and
22 years shows cSBP values slightly lower than those found
by Hidve´gi in the Hungarian population using the same
technology. Those observations were also valid in boys when
95th percentile was analyzed. However, in girls aged 10 to 17
years, these differences tend to disappear when considering
the 95th percentile. On the other hand, in comparison with
German database (Mobil-O-Graph System), our data shows
that cSBP values in the 50th and the 95th percentiles (both
sexes) were slightly higher in children below 10 years, and
significantly lower in adolescents over 13 years old than those
found by Elmenhorst et al. [18].
On the other hand, values of cAIx show a different
behavior with respect to age and gender. As was describe
above, our data show that females have higher cAIx values
than males (Table 1). These findings are in accordance with
the published data of Hidve´gi et al. who proved that after
15 years the AIx is higher in females than in males [17].
These authors reported that, in early childhood, the values
of AIx are high; however it decreases gradually with age in
both genders in ages between 12 and 15 years, increasing
afterwards. Moreover, the increased cAIx detected in early
childhood cannot be caused by the shorter return time, which
is determined by a shorter aortic length [17]. In Figure 5,
we compared cAIx percentiles 50th and 75th corresponding
ton males and females of the Argentinean population, with
those reported by Hidve´gi et al. [17]. It is noteworthy that
females of both populations exhibit similar cAIx curves, while
Argentinean males have lower values than the European
cohort before 12 y.o. and higher after ages over 13 y.o.
4.1. Methodological Considerations and Limitations. In this
observational study a noninvasive occlusive-oscillometric
device to assess arterial function parameters in children and
adolescents was used. This validated system provides central
aortic BP values that have shown significant correlation with
values of cSBP invasively assessed [6, 23]. On the other
hand, the use of an arm cuff facilitates epidemiological
studies performed in large cohort including children and
adolescents [14, 17, 33]. Moreover, the Arteriograph device
allows simultaneous quantification of Ao-PWV, AIx, cSBP,
and peripheral BP, and the procedure takes only 2-3min and
is well tolerated even in preschool children who experienced
only a little discomfort, similar to that observed during
noninvasive BP measurement [14].
The lack of standardization in methodologies used to
obtain RIs and/or normal values for cAIx, cSBP, and other
noninvasive obtained arterial parameters makes difficult to
compare different populations. In our research, we used
the statistical and methodological approach described by
the Reference Values for Arterial Measurements Collaboration
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Figure 4: Age specific aortic systolic blood pressure (cSBP) percentiles 95th and 50th obtained in males and females of the Argentinean
population compared with European date previously reported.
Group [27, 28]. This is not a minor point, since this strategy
allows us to compare our data with other databases available
around the world.
In this observational study, we used a cross-sectional
design; consequently, the relationship between cSBP and
cAIx with age should be interpreted with caution. However,
generation of these RIs should be generated taking advantage
approaches like that used in this research.
5. Conclusion
This study, performed in healthy children, adolescents, and
young adults from Argentina with ages 5 to 22 y.o., pro-
vides the first RIs and percentile curves of cSBP and cAIx.
Additionally, specific bodyheight-related cAIx percentiles are
reported for the analyzed population.The RIs and percentiles
contribute to the knowledge of arterial dynamic evolution
along the normal aging process and the interpretation of data
obtained in clinical research and daily clinical practice.
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Table A: age-related reference intervals (RIs) for central
(aortic) systolic blood pressure for the entire population
(𝑛 = 1038). Table B: age-related reference intervals (RIs)
for central (aortic) systolic blood pressure for males (𝑛 =
576). Table C: age-related reference intervals (RIs) for central
(aortic) systolic blood pressure for females (𝑛 = 462). Table
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1038). Table E: age-related reference intervals (RIs) for central
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F: age-related reference intervals (RIs) for central (aortic)
augmentation index (cAIx) for females (𝑛 = 462). Table
G: body height-related reference intervals (RIs) for central
(aortic) augmentation index (cAIx) for males (𝑛 = 576).
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Figure 5: Age specific central (aortic) augmentation index (cAIx) percentiles 75th and 50th obtained inmales and females of the Argentinean
population compared with Hidve´gi et al.’s date previously reported.
Table H: body height-related reference intervals (RIs) for
central (aortic) augmentation index (cAIx) for females (𝑛 =
462). (Supplementary Materials)
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